Ketamine International Journal Club and Conference
Ketamine & Related Compounds International Journal Club.
Founded November 2020 in Oxford, UK.
Upcoming events:
Oxford Ketamine Conference March 25-27th, 2024 - Programme to be announced in November 2023.
Past events:
Ketamine2022 - International Hybrid Conference, April 4th - 6th, 2022.
Ketamine2021 - Virtual Conference. March 25th-26th, 2021.
Independent of industry funding.
Programmed and run by academic clinicians at Oxford and psychiatric trainees.
Recently published papers on ketamine and related compounds for the treatment of psychiatric disorders.
Intended audience: clinicians, clinical and pre-clinical scientists, industry, policy makers.
Organisers:
Rupert McShane, Consultant Psychiatrist and Associate Professor, Oxford, UK
Sara Costi, Wellcome Trust Doctoral Fellow, Department Psychiatry, University of Oxford, Oxford, UK
Jacek Lindner, Clinical Fellow, Psychiatry Trainee, Oxford Health NHS Foundation Trust, Oxford UK
64.Effects of Chronic Social Isolation Stress and Alcohol on the Reinforcing Properties of Ketamine
63.Ketamine induces plasticity in a norepinephrine-astroglial circuit to promote behavioral persever
62.Ketamine plus midazolam compared to midazolam infusion for the management of refractory status ep
60.Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficac
59.Subanesthetic Ketamine Suppresses Locus Coeruleus–Mediated Alertness Effects: A 7T fMRI Study
058.Ketamine alleviates NMDA receptorhypofunction through synaptic trapping
Short talk: Routine EEG monitoring during ketamine treatment: preliminary results
EEG gamma oscillations as a prognostic marker for IV ketamine in TRD
Development and clinical translation of ultrasonic ketamine uncaging to treat affective disorders
Long-term safety and durable efficacy of esketamine in TRD and ESCAPE-TRD
Ketamine vs. ECT: implications for clinical practice, policy and future research
Opioid use reduces placebo response independently of pain in a ketamine depression trial
The misuse potential of medicinal (off-label) ketamine: RWE in the US
Comorbid PTSD and childhood trauma: impact on ketamine’s efficacy in TRD
Short talk: Ketamine for depression and PTSD in the military: an untapped opportunity?
Short talk: Influence of ketamine on the effect of expectations on perceptual and emotional learning
Where are we with the ketamine-opioid story?
Prucalopride (5HT4a agonist) plus ketamine: additive effects on stress
Glutamate and opioid mechanisms of antidepressant response to ketamine (GO-MARK)
From neurotoxicity to neuroplasticity: a lifesaving drug that must be used with respect
Welcome and house-keeping
Addiction potential of ketamine enantiomers and metabolites, and of esmethadone
R-Ketamine for Treatment Resistant Depression
Anatomy of melancholy – a preconference revision of neuroanatomy relevant to depression
Dose finding study of prolonged release oral ketamine formulation (Ketabon)
Mesmer, cardiac surgery, and ketamine: appreciating the power of contextual effects
Machine learning to predict response to ECT vs (es)ketamine
Short talk: IV esketamine in TRD - RWE following induction
Ketamine-assisted psychotherapies: a systematic review and historical overview
Short talk: Ketamine for depression with Anorexia Nervosa: the EDEN study